Brieflands
Journal finderSearch
·
Sign in

Koomesh

Journal of Semnan University of Medical Sciences

e-ISSN 2345-3699
p-ISSN 1608-7046
Home
Articles
    All IssuesIn PressAccepted ManuscriptsSearch
Instructions
About Journal
    Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Koomesh
  6. /
  7. Articles
  8. /
  9. Effect of topotycan and zinc oxide nanoparticles combination on cytotoxicity and P53 gene expression against breast cancer (MCF-7) cell line
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

5 results·Updated September 19, 2026
← Back to article
1

The Effect of Biosynthesized Zinc Oxide Nanoparticles Capped by Scenedesmus obliquus on Apoptosis and Gene Expression of p53 and VEGF in Breast Cancer Cell Line

Journal of Medicinal Plants and by Products

March and April 2025

Shirkhani Z.

2

Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?

Biological Trace Element Research

May 2024

Vaghari-Tabari M.

3

Evaluation of Cytotoxic and Apoptotic Effects of Green Synthesized Zn Oxide Nanoparticles on the MCF-7 breast cancer Cell Line

Koomesh

March-April 2023

Shishesaz P.

4

Evaluating the Toxicity of Doxorubicin-Silk Fibroin Nanoparticles and Its Effect on P53 Gene Expression in Breast Cancer Cell Line

Iranian Journal of Breast Diseases

2022

Vojdani Nejad Yazdi S.

Open Access

5

Green synthesis of zinc oxide nanoparticles by Zataria multiflora extract and evaluation of its antimicrobial, cytotoxic and apoptotic effects on HT-29 cell line

Koomesh

2022

Peymay Sabet B.J.

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.